Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)

IMPORTANCE: Sensitive outcome measures for disease progression are needed for treatment trials of Stargardt disease. OBJECTIVE: To describe the yearly progression rate of atrophic lesions in the retrospective Progression of Stargardt Disease study. DESIGN, SETTING, AND PARTICIPANTS: A multicenter re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Ophthalmol
Autors principals: Strauss, Rupert W., Muñoz, Beatriz, Ho, Alexander, Jha, Anamika, Michaelides, Michel, Cideciyan, Artur V., Audo, Isabelle, Birch, David G., Hariri, Amir H., Nittala, Muneeswar G., Sadda, SriniVas, West, Sheila, Scholl, Hendrik P. N.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2017
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710470/
https://ncbi.nlm.nih.gov/pubmed/29049437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2017.4152
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars